“Tanshinone IIA Attenuates Interleukin-17A-Induced Systemic Sclerosis Patient-Derived Dermal Vascular Smooth Muscle Cell Activation via Inhibition of the Extracellular Signal-Regulated Kinase Signaling Pathway”. Clinics 70, no. 4 (April 1, 2015): 250–256. Accessed June 17, 2024. https://revistas.usp.br/clinics/article/view/100991.